Difference between revisions of "NM Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
(Created page with "__NOTOC__ :Chairs: Richard Wahl, MD (Co-chair), Eric Perlman, MD (Co-chair), P. David Mozley, MD (Vice-chair) :Secretary: Susan Weinmann (RSNA Staff) :Roster: ''<link to roste...")
 
m
 
(20 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Chairs: Richard Wahl, MD (Co-chair), Eric Perlman, MD (Co-chair), P. David Mozley, MD (Vice-chair)
+
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
:Secretary: Susan Weinmann (RSNA Staff)
+
<br />RSNA Staff Support: Julie Lisiecki
:Roster: ''<link to roster of active attendees and who has voting privileges>''
+
 
 +
*[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster''']
 +
 
  
 
==Scope==  
 
==Scope==  
The NM Coordinating Committee coordinates Biomarker Committees based on NM.
+
The NM Coordinating Committee is responsible for:
 +
:* Monitoring and coordinating the activities of NM Biomarker Committees
 +
::* [https://docs.google.com/spreadsheets/d/1A7_uieyw0uu2DKbP6Vkzd37JuBEb2zmm-yqfXJtV-p4/edit?usp=sharing QIBA Profile Dashboard] (NM Page)
 
:* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]]
 
:* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]]
 
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
 
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
 
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
 
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
::* [[FDG-PET_Biomarker_Ctte]]
+
::*[[FDG-PET_Biomarker_Ctte]]
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[PET_Amyloid_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
 
::* [[SPECT_Biomarker_Ctte]]
 +
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
 +
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
 +
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
 +
  
 
==Meetings==
 
==Meetings==
  
* Tcons are held Quarterly. Contact the secretary for details.
+
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.

Latest revision as of 22:59, 17 May 2022

Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
RSNA Staff Support: Julie Lisiecki


Scope

The NM Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of NM Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the NM Biomarker Committees


Meetings

  • Zoom calls are held Quarterly. Please contact RSNA Staff for details.